Author

Kyungmi Han

OpenAlex ID: A5012860484

1105 A novel triple action and pre-clinical safety profile of SLC-3010 predict its favorable translation in the phase I clinical study

2022 · Woong Hee Yoon, Junhyeok Heo, et al. · Regular and Young Investigator Award Abstracts · 2

Abstract 3423: A novel triple action of SLC-3010 strengthens anti-tumor immunity by in vivo free TCB2/endogenous IL-2 complexing

2025 · Junhyeok Heo, Daeun Kim, et al. · Cancer Research

Works count: 2

Citation count: 2

H-index: 1

I10-index: